TBC1D23 inhibitors are a class of chemical compounds that target and inhibit the function of the TBC1D23 protein, a member of the TBC1 domain family of proteins. TBC1D23 plays a critical role in intracellular trafficking, specifically in the regulation of vesicle transport and membrane trafficking processes. Unlike many other TBC1 domain proteins that serve as GTPase-activating proteins (GAPs) for Rab GTPases, TBC1D23 is unique in that it does not directly regulate Rab GTPases but acts as a linker protein between vesicles and microtubule-associated motors. It helps coordinate the movement of vesicles along microtubules by connecting the transport machinery with components like sorting nexins and other vesicle-associated proteins. Inhibition of TBC1D23 disrupts this vesicle-to-motor connection, potentially leading to alterations in vesicle positioning, cargo sorting, and cellular trafficking routes.
Research involving TBC1D23 inhibitors provides significant insights into how vesicular transport is regulated at the molecular level. By blocking TBC1D23 function, scientists can explore how intracellular transport processes are disrupted and investigate the downstream effects on cargo delivery, recycling, and endosomal trafficking. TBC1D23 inhibitors are particularly useful for examining how this protein contributes to the spatial organization of vesicles within the cell and how it regulates the interaction between vesicles and the cytoskeleton. This class of inhibitors also helps elucidate the broader regulatory networks of vesicle trafficking and sorting, highlighting the critical role of TBC1D23 in maintaining cellular architecture and intracellular communication. Through the use of these inhibitors, researchers can gain a deeper understanding of the molecular machinery involved in vesicular transport and how disruptions in these processes affect overall cellular function.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 inhibitor. Since TBC1D23 is involved in trafficking between the endosome and the Golgi apparatus, and Cdc42 plays a role in vesicle formation, inhibition of Cdc42 can indirectly inhibit TBC1D23 function in vesicle trafficking. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 inhibits cytohesins, which regulate ARF family GTPases involved in vesicle formation. TBC1D23's role in vesicular trafficking depends on these processes, so SecinH3 would indirectly inhibit TBC1D23 by hindering vesicle formation and trafficking. | ||||||